Eisele Jeffrey

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Eisele Jeffrey's trades of Apellis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
63.69
Quantity 7,378
Value US$469,905
Transaction date
Proposed sale
Price
65.00
Quantity 1,607
Value US$104,449
Transaction date
Proposed sale
Price
65.58
Quantity 5,207
Value US$341,475
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-30 2025-01-29
S Sale
34,355 +23.7%
330.15
US$1,964,750 		34,355 +23.7% 330.15 US$1,964,750
2025-01-29 2025-01-29
PrS Proposed sale
5,450
392.91
US$4,846,819 		5,450 392.91 US$4,846,819
2025-01-23 2025-01-22
S Sale
2,418 -10.1%
57.30
US$4,488,248 		2,418 -10.1% 57.30 US$4,488,248
2025-01-22 2025-01-22
PrS Proposed sale
1,291
30.43
US$39,279 		1,291 30.43 US$39,279
2025-01-14 2025-01-13
S Sale
264 -0.5%
28.70
US$7,577 		264 -0.5% 28.70 US$7,577
2025-01-13 2025-01-13
PrS Proposed sale
264
28.70
US$7,576 		264 28.70 US$7,576
2024-12-27 2024-12-23
S Sale
63 -0.1%
33.09
US$2,085 		63 -0.1% 33.09 US$2,085
2024-12-23 2024-12-23
PrS Proposed sale
63
33.09
US$2,085 		63 33.09 US$2,085
2024-01-31 2024-01-30
PlS Planned sale
971 -1.7%
65.53
US$63,630 		971 -1.7% 65.53 US$63,630
2024-01-30 2024-01-30
PrS Proposed sale
971
65.53
US$63,630 		971 65.53 US$63,630
2024-01-31 2024-01-29
S Sale
279 -0.5%
64.14
US$17,895 		279 -0.5% 64.14 US$17,895
2024-01-29 2024-01-29
PrS Proposed sale
279
64.14
US$17,895 		279 64.14 US$17,895
2024-01-24 2024-01-23
PlS Planned sale
7,378 -11.2%
63.69
US$469,905 		7,378 -11.2% 63.69 US$469,905
2024-01-23 2024-01-23
PrS Proposed sale
7,378
63.69
US$469,905 		7,378 63.69 US$469,905
2024-01-23 2024-01-22
S Sale
1,607 -2.4%
65.00
US$104,449 		1,607 -2.4% 65.00 US$104,449
2024-01-22 2024-01-22
PrS Proposed sale
1,607
65.00
US$104,449 		1,607 65.00 US$104,449
2024-01-18 2024-01-17
PlS Planned sale
5,207 -7.2%
65.58
US$341,475 		5,207 -7.2% 65.58 US$341,475
2024-01-17 2024-01-17
PrS Proposed sale
5,207
65.58
US$341,475 		5,207 65.58 US$341,475
2024-01-17 2024-01-16
S Sale
438 -0.6%
66.81
US$29,262 		438 -0.6% 66.81 US$29,262
2024-01-16 2024-01-16
PrS Proposed sale
438
66.81
US$29,262 		438 66.81 US$29,262
2023-12-28 2023-12-27
PlS Planned sale
235 -0.4%
60.23
US$14,154 		235 -0.4% 60.23 US$14,154
2023-12-27 2023-12-27
PrS Proposed sale
235
60.23
US$14,154 		235 60.23 US$14,154
2023-12-28 2023-12-26
S Sale
68 -0.1%
57.86
US$3,935 		68 -0.1% 57.86 US$3,935
2023-12-26 2023-12-26
PrS Proposed sale
68
58.16
US$3,955 		68 58.16 US$3,955
2023-02-27 2023-02-23
PlS Planned sale
1,646 -3.0%
68.76
US$113,179 		1,646 -3.0% 68.76 US$113,179
2023-01-31 2023-01-30
PlS Planned sale
883 -1.9%
52.76
US$46,587 		883 -1.9% 52.76 US$46,587
2023-01-25 2023-01-23
PlS Planned sale
4,479 -8.6%
51.58
US$231,027 		4,479 -8.6% 51.58 US$231,027